PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
16.87%
Net income growth under 50% of MRVL's 152.48%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
1.79%
Some D&A expansion while MRVL is negative at -7.63%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
36.36%
Lower deferred tax growth vs. MRVL's 20334.48%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
4.26%
SBC growth while MRVL is negative at -5.16%. John Neff would see competitor possibly controlling share issuance more tightly.
-129.33%
Both reduce yoy usage, with MRVL at -76.66%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
25.10%
AR growth well above MRVL's 31.88%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
1.35%
Some inventory rise while MRVL is negative at -105.36%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
-233.33%
Negative yoy AP while MRVL is 235.23%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-97.81%
Both reduce yoy usage, with MRVL at -115.35%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
No Data
No Data available this quarter, please select a different quarter.
-20.85%
Negative yoy CFO while MRVL is 26.16%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-29.22%
Negative yoy CapEx while MRVL is 44.82%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-2.00%
Negative yoy purchasing while MRVL stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
43.04%
Liquidation growth of 43.04% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
No Data
No Data available this quarter, please select a different quarter.
500.00%
Investing outflow well above MRVL's 45.22%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
100.00%
We repay more while MRVL is negative at -2.08%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
No Data
No Data available this quarter, please select a different quarter.
-48.81%
We cut yoy buybacks while MRVL is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.